SelCheck is the screening device that allows individuals to self-check their disease risk easily. By analyzing the acquired data, we aim to build healthcare solutions that contribute to the prevention and early detection of diseases that are difficult to detect. Look below to learn about our cervical cancer screening offering, as well as upcoming SelCheck services.
SelCheck Cervical Cancer Screening
CMIC Group provides the Japanese public with SelCheck Cervical Cancer screening device, an HPV test that patients can use at home to self-collect samples themselves. Individual patients then mail their samples to the CMIC Group lab. Test results are available via website: with results reported as either positive, negative or cannot be measured. If there is a positive result, patients are informed if a high-risk type, such as HPV-16 or HPV-18, or another type has been detected.
Our Edge in Cervical Cancer Screening
Improving cervical cancer screening rates in Japan
- Self-extracting HPV testing device, that applicants can use to self-collect samples and mail on their own to a CMIC Group lab.
- The company provides an option for patients to receive extensive free follow-up from a nurse consultation service and also assistance finding a medical institution, to ensure patients who need follow-up for high-risk HPV receive appropriate care.
Upcoming SelCheck Services:
- Sleep Disorders
- Mental State